+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Acute Pain Medicine"

Acute Pain - Pipeline Insight, 2024 - Product Thumbnail Image

Acute Pain - Pipeline Insight, 2024

  • Drug Pipelines
  • April 2024
  • 80 Pages
  • Global
From
Chronic and Acute pain - Pipeline Insight, 2024 - Product Thumbnail Image

Chronic and Acute pain - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 60 Pages
  • Global
From
Moderate To Severe Acute Pain - Pipeline Insight, 2024 - Product Thumbnail Image

Moderate To Severe Acute Pain - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 60 Pages
  • Global
From
From
From
United States OLINVYK Drug Insight and Market Forecast - 2032 - Product Thumbnail Image

United States OLINVYK Drug Insight and Market Forecast - 2032

  • Drug Pipelines
  • November 2023
  • 30 Pages
  • United States
From
United States DSUVIA Drug Insight and Market Forecast - 2032 - Product Thumbnail Image

United States DSUVIA Drug Insight and Market Forecast - 2032

  • Drug Pipelines
  • November 2023
  • 30 Pages
  • United States
From
United States MAXIGESIC IV Drug Insight and Market Forecast - 2032 - Product Thumbnail Image

United States MAXIGESIC IV Drug Insight and Market Forecast - 2032

  • Drug Pipelines
  • November 2023
  • 30 Pages
  • United States
From
United States ANJESO Drug Insight and Market Forecast - 2032 - Product Thumbnail Image

United States ANJESO Drug Insight and Market Forecast - 2032

  • Drug Pipelines
  • November 2023
  • 30 Pages
  • United States
From
Postoperative Pain - Epidemiology Forecast - 2032 - Product Thumbnail Image

Postoperative Pain - Epidemiology Forecast - 2032

  • Drug Pipelines
  • March 2022
  • 162 Pages
  • Global
From
From
From
Acute Pain - Epidemiology Forecast to 2032 - Product Thumbnail Image

Acute Pain - Epidemiology Forecast to 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
From
From
Chronic and Acute pain - Epidemiology Forecast to 2032 - Product Thumbnail Image

Chronic and Acute pain - Epidemiology Forecast to 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
Moderate To Severe Acute Pain - Epidemiology Forecast to 2032 - Product Thumbnail Image

Moderate To Severe Acute Pain - Epidemiology Forecast to 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
US Acute Pain Market and Competitive Landscape - 2022 - Product Thumbnail Image

US Acute Pain Market and Competitive Landscape - 2022

  • Report
  • August 2022
  • United States
From
From
From
Loading Indicator

Analgesics are a class of drugs used to treat pain. Acute pain medicine is a subset of analgesics used to treat short-term, severe pain. Acute pain medicine is typically used to treat pain caused by injury, surgery, or other medical conditions. Common acute pain medicines include non-steroidal anti-inflammatory drugs (NSAIDs), opioids, and acetaminophen. NSAIDs are used to reduce inflammation and pain, while opioids are used to treat more severe pain. Acute pain medicines are available in both prescription and over-the-counter forms. Acute pain medicine is a large and growing market. It is estimated that the global market for acute pain medicine will reach $50 billion by 2025. The market is driven by an aging population, increasing prevalence of chronic pain, and the development of new drugs. Some companies in the acute pain medicine market include Pfizer, Johnson & Johnson, Merck, Novartis, and GlaxoSmithKline. Show Less Read more